HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lina M Obeid Selected Research

spisulosine

1/20221-Deoxysphinganine initiates adaptive responses to serine and glycine starvation in cancer cells via proteolysis of sphingosine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lina M Obeid Research Topics

Disease

45Neoplasms (Cancer)
01/2022 - 10/2004
16Inflammation (Inflammations)
01/2021 - 02/2008
14Breast Neoplasms (Breast Cancer)
07/2021 - 10/2002
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2009
6Colonic Neoplasms (Colon Cancer)
01/2018 - 02/2006
6Carcinogenesis
12/2017 - 02/2006
5Neoplasm Metastasis (Metastasis)
07/2021 - 08/2012
4Adenocarcinoma of Lung
11/2019 - 04/2002
4Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 10/2002
4Colitis
01/2017 - 01/2009
4Neuroblastoma
05/2012 - 11/2003
4Squamous Cell Carcinoma of Head and Neck
03/2011 - 10/2004
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 05/2011
3Hypoxia (Hypoxemia)
11/2011 - 02/2008
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2017
2Starvation
01/2022 - 01/2021
2Lung Neoplasms (Lung Cancer)
11/2019 - 09/2005
2Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 01/2018
2Cerebellar Ataxia (Dysmetria)
01/2018 - 10/2015
2Ulcerative Colitis
01/2018 - 01/2017
2Splenomegaly
01/2017 - 01/2009
2Arthritis (Polyarthritis)
10/2013 - 08/2010
2Rheumatoid Arthritis
01/2013 - 12/2011
2Hyperalgesia
08/2011 - 07/2011
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2011 - 04/2007
2Glioma (Gliomas)
08/2010 - 02/2008
2Necrosis
01/2009 - 03/2005
2Carcinoma (Carcinomatosis)
05/2008 - 10/2004
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019
1Stroke (Strokes)
11/2019
1Hereditary Sensory and Autonomic Neuropathies (HSAN)
11/2018
1Type 2F Charcot-Marie-Tooth disease
01/2018

Drug/Important Bio-Agent (IBA)

39CeramidesIBA
01/2021 - 04/2002
31SphingolipidsIBA
01/2021 - 02/2008
29sphingosine kinaseIBA
01/2022 - 09/2005
23sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021 - 04/2007
16EnzymesIBA
01/2021 - 03/2006
9SphingosineIBA
01/2022 - 02/2008
6Messenger RNA (mRNA)IBA
01/2021 - 04/2002
6Alkaline CeramidaseIBA
01/2018 - 09/2010
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2017 - 02/2006
5LipidsIBA
01/2022 - 02/2008
5Proteins (Proteins, Gene)FDA Link
11/2015 - 04/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2013 - 03/2005
4Neutral CeramidaseIBA
01/2022 - 12/2012
4CytokinesIBA
01/2018 - 08/2010
4AzoxymethaneIBA
12/2017 - 02/2006
4Phosphotransferases (Kinase)IBA
01/2015 - 08/2011
4Small Interfering RNA (siRNA)IBA
10/2013 - 02/2006
4dihydroceramide desaturaseIBA
05/2012 - 06/2007
4Cytochromes c (Cytochrome c)IBA
09/2008 - 10/2002
3Biological ProductsIBA
01/2022 - 10/2004
3Serine (L-Serine)FDA Link
01/2022 - 11/2018
3Acid CeramidaseIBA
01/2018 - 09/2007
3Dinoprostone (PGE2)FDA Link
12/2017 - 02/2006
3Interleukin-6 (Interleukin 6)IBA
01/2015 - 08/2013
3Dextran SulfateIBA
01/2014 - 01/2009
3Sphingosine-1-Phosphate ReceptorsIBA
08/2012 - 02/2008
3SphingomyelinsIBA
09/2008 - 10/2002
3Caspase 9IBA
06/2006 - 04/2002
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2005 - 11/2003
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2017
2Alanine (L-Alanine)FDA Link
01/2022 - 11/2018
2PalmitatesIBA
07/2021 - 08/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2018
2CateninsIBA
01/2018 - 12/2016
2IsoenzymesIBA
01/2017 - 01/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2015 - 03/2003
2p38 Mitogen-Activated Protein KinasesIBA
01/2015 - 02/2013
23- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA
10/2013 - 01/2013
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
02/2013 - 08/2011
2Prostaglandins EIBA
02/2013 - 08/2011
2ProstaglandinsIBA
08/2011 - 05/2008
2FenretinideIBA
07/2011 - 09/2010
2Imatinib Mesylate (Gleevec)FDA Link
06/2011 - 04/2007
2Caspase 3 (Caspase-3)IBA
03/2011 - 06/2006
1TransferasesIBA
01/2022
1Palmitoyl Coenzyme A (Palmitoyl CoA)IBA
01/2022
1spisulosineIBA
01/2022
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2022
1Olive OilIBA
07/2021
1Tumor Viral Antigens (Large T Antigen)IBA
07/2021
1Fatty Acids (Saturated Fatty Acids)IBA
07/2021
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2021
1Oleic Acid (Oleate)IBA
07/2021
1Myristic Acid (Tetradecanoic Acid)IBA
07/2021
1ceramide kinaseIBA
01/2021
1GalactosidasesIBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
11/2019
1Mechanistic Target of Rapamycin Complex 1IBA
11/2019
1Protein Kinases (Protein Kinase)IBA
11/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1CarcinogensIBA
01/2018

Therapy/Procedure

7Therapeutics
01/2018 - 06/2006
4Drug Therapy (Chemotherapy)
02/2012 - 01/2005
3Chemoprevention
02/2013 - 02/2009
1Mediterranean Diet
07/2021